This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Phase II
Phase II
Clinical trials of about 100-300 subjects with the condition of interest; includes pharmacokinetic, dose ranging, safety and efficacy, and is well-controlled.